Enterprise Value to EBITDA Multiple ratio Analysis of Xenetic Biosciences Inc - Deep Dive
Latest FY EV to EBITDA
Period Ending - Dec-23
Excellent EV to EBITDA
0.694
Period Ending - Dec-22
Excellent EV to EBITDA
1.17
Growth
-40.48 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Excellent EV to EBITDA
0.624
EV to EBITDA Analysis of Xenetic Biosciences Inc
Enterprise Value to EBITDA 0.694 of Xenetic Biosciences Inc indicate that a company is more attractive or undervalued in the market. |
EV to EBITDA Ratio of XBIO drastically fell by -40.48 % this year. |
EV to EBITDA Ratio with value of 2.81 was highest in Year Dec-21 in last Five Years. |
EV to EBITDA Ratio with value of 0.655 was lowest in Year Dec-20 in last Five Years. |
Latest EV to EBITDA Ratio with value of 0.694 is lower than Average EV to EBITDA of 1.21 in last five years. |
Other EV to EBITDA Related Info of XBIO that may interest you.
Xenetic Biosciences Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
XBIO | 3.8598 | 3.767 | 2.46 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..EV to EBITDA Related Ratios
EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
No Significant Value |
FY - Historical Enterprise Value to EBITDA Multiple of Xenetic Biosciences Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
EV to EBITDA | 0.694 | 1.17 | 2.81 | 0.655 | 0.725 | 0.075 | 1.54 |
Change | -40.48 % | -58.48 % | 328.79 % | -9.74 % | 865.51 % | -95.13 % | 1947.77 % |
FY Chart of Enterprise Value to EBITDA Multiple of Xenetic Biosciences Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)